ORK Stock Analysis: Orkla ASA | OL
Packaged Foods | OL, Norway | Market Cap: 87.302m NOK | 12M Return: -6.4% | NO0003733800 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 156M
EPS Trend: 98.0%
Qual. Beats: 0
Rev. Trend: 92.9%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Orkla ASA is a Norwegian industrial investment company headquartered in Oslo, with origins dating back to 1654. The company operates a diversified portfolio of brands and consumer-oriented businesses across multiple categories worldwide.
Its operations span decorative paints and coatings, frozen and ready-to-eat foods, confectionery, biscuits, and salty snacks, as well as branded consumer health products including nutrition, oral care, wound care, and personal care under names like Möllers, Jordan, and Salvequick. The company also offers spices, cleaning products, and runs a franchised pizza business, alongside painting supplies and health and sports nutrition products.
Orklas structure as an industrial investment company with such a broad, multi-sector consumer portfolio is relatively unusual within the European packaged foods space, where peers typically concentrate on fewer product categories. Its paints and coatings segment places it in competition with specialty chemical and paint manufacturers, while its food and snacks business operates alongside major Nordic and European packaged goods firms.
- Branded food portfolio grows on price-mix and innovation launches
- Paints and coatings margins pressured by raw material cost inflation
- M&A pipeline targets health, nutrition and adjacent consumer categories
| Net Income: 6.82b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.44 > 1.0 |
| NWC/Revenue: 3.62% < 20% (prev 5.50%; Δ -1.88% < -1%) |
| CFO/TA 0.17 > 3% & CFO 15.0b > Net Income 6.82b |
| Net Debt (876.0m) to EBITDA (11.9b): 0.07 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (968.6m) vs 12m ago -3.09% < -2% |
| Gross Margin: 48.54% > 18% (prev 50.56%; Δ -2.02% > 0.5%) |
| Asset Turnover: 80.70% > 50% (prev 80.82%; Δ -0.13% > 0%) |
| Interest Coverage Ratio: 11.99 > 6 (EBIT TTM 9.19b / Interest Expense TTM 766.0m) |
| A: 0.03 (Total Current Assets 23.2b - Total Current Liabilities 20.7b) / Total Assets 87.5b |
| B: 0.46 (Retained Earnings 40.4b / Total Assets 87.5b) |
| C: 0.10 (EBIT TTM 9.19b / Avg Total Assets 87.8b) |
| D: 1.02 (Book Value of Equity 42.3b / Total Liabilities 41.7b) |
| Altman-Z'' = 3.47 = A |
| DSRI: 1.02 (Receivables 9.27b/9.11b, Revenue 70.8b/71.1b) |
| GMI: 1.04 (GM 50.56% / 48.54%) |
| AQI: 0.98 (AQ_t 0.52 / AQ_t-1 0.53) |
| SGI: 1.00 (Revenue 70.8b / 71.1b) |
| TATA: -0.09 (NI 6.82b - CFO 15.0b) / TA 87.5b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 12, 2026, the stock is trading at NOK 93.05 with a total of 1,476,658 shares traded. Over the past week, the price has changed by +1.47%, over one month by +1.97%, over three months by -11.80% and over the past year by -6.35%.
Current recommended Stop Loss: 91.40 (which is 1.8% or 1.2 ATR below the current price).
Orkla ASA has no consensus analysts rating.
P/E Trailing = 13.8508
P/E Forward = 13.7741
P/S = 1.2327
P/B = 2.118
P/EG = 1.138
Revenue TTM = 70.8b NOK
EBIT TTM = 9.19b NOK
EBITDA TTM = 11.9b NOK
Long Term Debt = 13.9b NOK (from longTermDebt, last quarter)
Short Term Debt = 6.47b NOK (from shortLongTermDebt, last quarter)
Debt = 2.32b NOK (Leases only: 2.32b)
Net Debt = 876.0m NOK (calculated: Debt 2.32b - CCE 1.45b)
Enterprise Value = 88.2b NOK (87.3b + Debt 2.32b - CCE 1.45b)
Interest Coverage Ratio = 11.99 (Ebit TTM 9.19b / Interest Expense TTM 766.0m)
EV/FCF = 13.10x (Enterprise Value 88.2b / FCF TTM 6.73b)
FCF Yield = 7.63% (FCF TTM 6.73b / Enterprise Value 88.2b)
FCF Margin = 9.50% (FCF TTM 6.73b / Revenue TTM 70.8b)
Net Margin = 9.62% (Net Income TTM 6.82b / Revenue TTM 70.8b)
Gross Margin = 48.54% ((Revenue TTM 70.8b - Cost of Revenue TTM 36.4b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.01 (Enterprise Value 88.2b / Total Assets 87.5b)
Interest Expense / Debt = 32.97% (Interest Expense 766.0m / Debt 2.32b)
Taxrate = 16.33% (1.38b / 8.42b)
NOPAT = 7.69b (EBIT 9.19b * (1 - 16.33%))
Current Ratio = 1.12 (Total Current Assets 23.2b / Total Current Liabilities 20.7b)
Debt / Equity = 0.05 (Debt 2.32b / totalStockholderEquity, last quarter 42.3b)
Debt / EBITDA = 0.07 (Net Debt 876.0m / EBITDA 11.9b)
Debt / FCF = 0.13 (Net Debt 876.0m / FCF TTM 6.73b)
Total Stockholder Equity = 46.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.77% (Net Income 6.82b / Total Assets 87.5b)
RoE = 14.76% (Net Income TTM 6.82b / Total Stockholder Equity 46.2b)
RoCE = 15.30% (EBIT 9.19b / Capital Employed (Equity 46.2b + L.T.Debt 13.9b))
RoIC = 11.76% (NOPAT 7.69b / Invested Capital 65.4b)
WACC = 5.82% (E(87.3b)/V(89.6b) * Re(5.24%) + D(2.32b)/V(89.6b) * Rd(32.97%) * (1-Tc(0.16)))
Discount Rate = 5.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 71.32 | Cagr: 0.12%
[DCF] Terminal Value 74.60% ; FCFF base≈6.90b ; Y1≈6.58b ; Y5≈6.30b
[DCF] Fair Price = 102.3 (EV 99.0b - Net Debt 876.0m = Equity 98.2b / Shares 959.4m; r=8.35% [WACC [floored]]; 5y FCF grow -5.94% → 2.50% )
EPS Correlation: 97.95 | EPS CAGR: 7.39% | SUE: 0.27 | # QB: 0
Revenue Correlation: 92.88 | Revenue CAGR: 2.73% | SUE: -1.96 | # QB: -1
EPS current Quarter (2026-09-30): EPS=1.69 | Chg30d=-0.05% | Revisions=-17% | Analysts=5
EPS current Year (2026-12-31): EPS=6.62 | Chg30d=+0.04% | Revisions=+17% | GrowthEPS=-3.0% | GrowthRev=-1.3%
EPS next Year (2027-12-31): EPS=6.86 | Chg30d=+0.16% | Revisions=-38% | GrowthEPS=+3.6% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: -21% (up=4, down=7)